Reducing Rx Copays Improves Medication AdherenceReducing prescription drug copays for workers with chronic diseases increases their medication adherence, reports a group of doctors. Their study examined copays and utilization within the context of a disease management program.
Following a similar strategy used by Pitney Bowes in 2002, the employer in the study reduced its copays for medications treating heart diseases, diabetes, high cholesterol and asthma. Copays for generic medications were reduced from $5 to zero, while copays for brand-name drugs were lowered from $25 to $12.50.
To read more click on Reducing RX Copays.